Palatin enrols first subject in Phase II ulcerative colitis therapy trial

Palatin enrols first subject in Phase II ulcerative colitis therapy trial

Submitted by admin on October 21, 2022 - 10:41am
Source: 
Clinical Trials Arena
News Tags: 
Palatin Technologies
ulcerative colitis
PL8177
clinical trials
Headline: 
Palatin enrols first subject in Phase II ulcerative colitis therapy trial
snippet: 

Palatin Technologies has announced the enrolment of the first patient in the Phase II PL8177-205 clinical trial of PL8177 for ulcerative colitis (UC), a chronic large intestine disease.

Do Not Allow Advertisers to Use My Personal information